- Q2 2024 Eris Lifesciences Ltd Earnings Call TranscriptNov 08, 2023₹897.8 (+3.30%)Earnings
- Q1 2024 Eris Lifesciences Ltd Earnings Call TranscriptAug 07, 2023₹828.2 (+3.45%)Earnings
- Q4 2023 Eris Lifesciences Ltd Earnings Call TranscriptMay 17, 2023₹636.65 (+1.06%)Earnings
- Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call TranscriptMar 16, 2023
- Q3 2023 Eris Lifesciences Ltd Earnings Call TranscriptJan 17, 2023₹651.8 (+0.50%)Earnings
- Q2 2023 Eris Lifesciences Ltd Earnings Call TranscriptOct 20, 2022₹707.85 (-2.92%)Earnings
- Q1 2023 Eris Lifesciences Ltd Earnings Call TranscriptAug 05, 2022₹694.75 (-0.81%)Earnings
- Q4 2022 Eris Lifesciences Ltd Earnings Call TranscriptMay 04, 2022₹663.35 (-1.86%)Earnings
- Q3 2022 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2022₹696.2 (-2.04%)Earnings
- Eris Lifesciences Ltd To Discuss Joint Venture with Mj Biopharm Pvt Ltd Call TranscriptDec 04, 2021
- Q2 2022 Eris Lifesciences Ltd Earnings Call TranscriptOct 29, 2021₹821 (+4.73%)Earnings
- Q1 2022 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2021₹771.15 (+3.91%)Earnings
- Q4 2021 Eris Lifesciences Ltd Earnings Call TranscriptMay 13, 2021₹653.85Earnings
- Q3 2021 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2021₹623.1 (+2.03%)Earnings
- Q2 2021 Eris Lifesciences Ltd Earnings Call TranscriptNov 03, 2020₹518.1 (+1.46%)Earnings
- Q1 2021 Eris Lifesciences Ltd Earnings Call TranscriptAug 04, 2020₹510.95 (-5.48%)Earnings
- Q4 2020 Eris Lifesciences Ltd Earnings Call TranscriptJun 02, 2020₹519.2 (-1.59%)Earnings
- Q3 2020 Eris Lifesciences Ltd Earnings Call TranscriptFeb 14, 2020₹465.5 (-11.33%)Earnings
- Q2 2020 Eris Lifesciences Ltd Earnings Call TranscriptNov 07, 2019₹425.55 (+4.61%)Earnings
- Q1 2020 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2019₹394.8 (-1.62%)Earnings
- Q4 2019 Eris Lifesciences Ltd Earnings Call TranscriptMay 21, 2019₹605.6 (-1.37%)Earnings
Q4 2021 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Eris Lifesciences Q4 FY '21 Results Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. V Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Good afternoon, and welcome to our Q4 conference call. I'm Krishnakumar, and I'm happy to share the highlights of the quarter as well as the entire year with you.
In terms of financial highlights, I'm happy to report that our Q4 stand-alone revenue grew by 11.3% year-on-year to INR 257 crores and our Q4 consolidated revenue grew by 11.9% to INR 278 crores. As per AIOCD, in quarter 4, the Indian pharma market registered a 5.3% growth, bringing up the FY '21 growth to 2.1%. As expected, most of the growth gained from chronic and subchronic therapies, which grew by 7.7% in Q4 and 5.7% when you take overall FY '21. However, the AIOCD data in Q4 showed a growth of 2% for Eris, which was on account of a high base in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)